Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for LungFit PH® in Europe and Market Authorization in Australia; internationa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback